All countries should closely monitor adverse health effects related to the use of any vaccine, a spokesperson for the World Health Organization (WHO) told Sputnik following the suspension of the AstraZeneca drug in several EU countries.
A number of European states have suspended vaccination with the AstraZeneca drug as a precaution after reports on severe side-effects, including blood clots, that were allegedly triggered by the vaccine. The European Medicines Agency said there was currently no indication that the reported negative effects had been caused by the vaccination.
"WHO encourages all countries to continue to carefully monitor for any adverse events following immunization (AEFIs) with any vaccine and to report any serious cases of AEFIs to the global AEFI surveillance database," the spokesperson said on late Thursday.
The WHO's Global Advisory Committee on Vaccine Safety (GACVS) reviews all the reports on the vaccines' safety, according to the organization's representative.
"WHO's Global Advisory Committee on Vaccine Safety (GACVS) systematically reviews any vaccine safety signals and concerns related to COVID-19 vaccine safety, to advise WHO on any new safety signals or concerns related to COVID-19 vaccines," the spokesperson said.
The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020. To date, more than 118.34 million people have been infected with the coronavirus worldwide, with over 2.62 million fatalities, according to Johns Hopkins University.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)